Therapeutic cancer vaccines

M Saxena, SH van der Burg, CJM Melief… - Nature Reviews …, 2021 - nature.com
Therapeutic cancer vaccines have undergone a resurgence in the past decade. A better
understanding of the breadth of tumour-associated antigens, the native immune response …

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone Research, 2023 - nature.com
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment

KV Myers, SR Amend, KJ Pienta - Molecular cancer, 2019 - Springer
Tumor-associated macrophages are an abundant cell type in the tumor microenvironment.
These macrophages serve as a promising target for treatment of cancer due to their roles in …

The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer

S Edin, ML Wikberg, AM Dahlin, J Rutegård, Å Öberg… - 2012 - journals.plos.org
High macrophage infiltration has been correlated to improved survival in colorectal cancer
(CRC). Tumor associated macrophages (TAMs) play complex roles in tumorigenesis since …

Identification and manipulation of tumor associated macrophages in human cancers

M Heusinkveld, SH van Der Burg - Journal of translational medicine, 2011 - Springer
Evading immune destruction and tumor promoting inflammation are important hallmarks in
the development of cancer. Macrophages are present in most human tumors and are often …

Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents

EP Buddingh, ML Kuijjer, RAJ Duim, H Bürger… - Clinical Cancer …, 2011 - AACR
Purpose: High-grade osteosarcoma is a malignant primary bone tumor with a peak
incidence in adolescence. Overall survival (OS) of patients with resectable metastatic …

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

S Rusakiewicz, M Semeraro, M Sarabi, M Desbois… - Cancer research, 2013 - AACR
Cancer immunosurveillance relies on effector/memory tumor-infiltrating CD8+ T cells with a
T-helper cell 1 (TH1) profile. Evidence for a natural killer (NK) cell-based control of human …

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

VP Balachandran, MJ Cavnar, S Zeng, ZM Bamboat… - Nature medicine, 2011 - nature.com
Imatinib mesylate targets mutated KIT oncoproteins in gastrointestinal stromal tumor (GIST)
and produces a clinical response in 80% of patients. The mechanism is believed to depend …

Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers

B Li, H Chen, S Yang, F Chen, L Xu, Y Li, M Li, C Zhu… - Molecular cancer, 2023 - Springer
Mesenchymal gastrointestinal cancers are represented by the gastrointestinal stromal
tumors (GISTs) which occur throughout the whole gastrointestinal tract, and affect human …

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

M Heusinkveld, PJ de Vos van Steenwijk… - The Journal of …, 2011 - journals.aai.org
Monocytes attracted by tumor-induced chronic inflammation differentiate to APCs, the type of
which depends on cues in the local tumor milieu. In this work, we studied the influence of …